Unlock instant, AI-driven research and patent intelligence for your innovation.

Dendritic cells expressing chimeric antigen receptors and uses thereof

A technology of chimeric antigen receptors and dendritic cells, applied to receptors/cell surface antigens/cell surface determinants, anti-receptors/cell surface antigens/cell surface determinants immunoglobulins, and the introduction of foreign genetic material Modified cells and other directions can solve problems affecting the efficacy of cellular immunity and off-target toxicity

Active Publication Date: 2019-03-15
SHILI BIOTECH CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

T cells expressing CAR recognize and bind tumor antigens in an antigen-dependent, but not MHC-restricted manner, and initiate and activate a specific anti-tumor response; however, CAR-T can produce certain off-target toxicity, which affects its cellular immune efficacy. There is a need to develop a new approach and immunotherapy cells to address the above issues

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dendritic cells expressing chimeric antigen receptors and uses thereof
  • Dendritic cells expressing chimeric antigen receptors and uses thereof
  • Dendritic cells expressing chimeric antigen receptors and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] 1. Determination of mesoCAR gene sequence

[0074] 1.1 The human GM-CSF signal peptide gene, human CD8α hinge region gene, human CD40 transmembrane region and Intracellular signal region gene sequence. Anti-mesothelin single-chain antibody (anti-SS1 scFv) gene sequence.

[0075] 1.2 The above gene sequences were sequentially connected according to the human GM-CSF signal peptide gene, anti-SS1scFv, human CD8α hinge region gene, human CD40 transmembrane region and intracellular signal region sequence to form the final complete GM-CSF-SS1scFv-CD8α- CD40 (mesoCAR) gene sequence SEQ ID NO.4.

[0076] 2. Construction of pCDH-mesoCAR expression plasmid

[0077] 2.1 Whole gene synthesis:

[0078] The complete mesoCAR gene sequence was synthesized by Shanghai Sangon, and restriction sites Xba I / EcoR I were added at both ends.

[0079] 2.2 Cloning the above sequence into pCDH-CMV-MCS-EF1-copGFP-T2A-puro (pCDH for short) lentiviral expression vector to obtain the expression ...

Embodiment 2

[0125] 1. Determination of EGFRvIIICAR gene sequence

[0126] 1.1 Obtain the human CD8α signal peptide gene, human CD8α hinge region gene, human CD40 transmembrane region and human CD40 signal domain from the GenBank database on the website of the National Library of Medicine (http: / / www.ncbi.nlm.nih.gov / entrez) gene sequence. Human CD8α signal peptide gene, EGFRvIII scFv light chain gene, linker region (Gly4-Ser) 3 , EGFRvIII scFv heavy chain gene, human CD8α hinge region gene, human CD40 transmembrane region and human CD40 signal domain gene sequence were connected to form the final complete EGFRvIIICAR gene sequence (SEQ ID NO.5) information.

[0127] 2. Construction of EGFRvIIICAR expression plasmid

[0128] 2.1 Whole gene synthesis:

[0129] The complete EGFRvIIICAR sequence was synthesized by Shanghai Sangon Biotechnology Co., Ltd., and an XbaI restriction site was added to its 5' end, and an EcoR I restriction site was added to the 3' end.

[0130] 2.2 Amplify the E...

Embodiment 3

[0169] 1. Construction of MOv19CAR expression plasmid

[0170] 1.1 The human CD8α signal peptide gene, human CD8α hinge region gene, human CD40 transmembrane region and intracellular Signal region gene sequence. MOv19 single chain antibody (anti-alpha folate receptor scFv) gene sequence.

[0171] 1.2 The above gene sequence was sequentially formed according to the human CD8α signal peptide gene, MOv19scFv, human CD8α hinge region gene, human CD40 transmembrane region and CD40 intracellular signal region sequence to form a complete MOv19CAR gene sequence (SEQ ID NO.6); in sequence 5 An EcoRI restriction site was introduced at the 'end of the sequence, and a BamHI restriction site was introduced at the 3' end of the sequence, which was handed over to Shanghai Sangon Biotechnology Co., Ltd. for synthesis. After the plasmid was synthesized, the MOv19-CAR was digested from the pUC57 plasmid, and at the same time the enzyme Cut pCDH empty plasmid, the enzyme cutting system is as f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a dendritic cell for expressing a chimeric antigen receptor, a preparation method of the dendritic cell, and a purpose of the dendritic cell to preparation of a tumor treatment preparation.

Description

technical field [0001] The invention belongs to the field of tumor biological products, and in particular relates to dendritic cells for expressing chimeric antigen receptors, a preparation method thereof, and the use of the dendritic cells in preparing preparations for treating tumors. Background technique [0002] Dendritic cells (DC) are a type of mature cells with many dendritic protrusions, capable of recognizing, ingesting and processing exogenous antigens and presenting antigenic peptides to naive T cells and inducing T cell activation and proliferation. The most powerful antigen-presenting cells. [0003] The current DC cell immunotherapy is to isolate the tumor patient's own monocytes, culture, expand and induce them to generate DCs in vitro, and then let the DCs load the corresponding tumor antigens, and prepare DCs loaded with tumor antigens after strict screening , and then reinfuse these DC cells back into the corresponding patients to stimulate and activate th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/10C12N15/867A61K35/15A61P35/00
CPCA61K35/15C07K14/7051C07K16/30C07K2319/02C07K2319/03C07K2319/33C12N15/86C12N2740/15043
Inventor 樊克兴陈青峰
Owner SHILI BIOTECH CO LTD